Richard S Levy has an estimated net worth of $71.7 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, MADRIGAL PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Kiniksa Pharmaceuticals International, plc, Kodiak Sciences Inc., AQUINOX PHARMACEUTICALS, INC, and Protara Therapeutics, Inc..

2014 was Richard S Levy's most active year for acquiring shares with 21 total transactions. Richard S Levy's most active month to acquire stocks was the month of May. 2015 was Richard S Levy's most active year for disposing of shares, totalling 34 transactions. Richard S Levy's most active month to dispose stocks was the month of October. 2023 saw Richard S Levy paying a total of $2,316,844.12 for 114,850 shares, this is the most they've acquired in one year. In 2014 Richard S Levy cashed out on 620,096 shares for a total of $19,448,485.73, their largest year based on trade value.